Co-targeting EGFR and survivin with a bivalent aptamer-dual siRNA chimera effectively suppresses prostate cancer
Crossref DOI link: https://doi.org/10.1038/srep30346
Published Online: 2016-07-26
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Liu, Hong Yan
Yu, Xiaolin
Liu, Haitao
Wu, Daqing
She, Jin-Xiong
Text and Data Mining valid from 2016-07-26
Version of Record valid from 2016-07-26
Article History
Received: 4 January 2016
Accepted: 4 July 2016
First Online: 26 July 2016
Competing interests
: The authors declare no competing financial interests.